Profile: Bristol Myers Squibb offers drugs for cardiovascular diseases, neurology, virology, oncology, rheumatoid arthritis, and pain therapy. We deal with the treatment of mental disorders, cancer, HIV/AIDS and other serious diseases including two therapeutic protein derivatives, known as biologics.

The company has revenues of USD 100-500 Million, has ~800 employees. NYSE:BMY-P (SEC Filings)